Market Place
Sourcing Support
Tolremo Therapeutics Granted Dual FDA Fast Track Status
28 Aug 2025 //
GLOBENEWSWIRE
TOLREMO therapeutics Announces Strengthening of Leadership
18 Jun 2025 //
GLOBENEWSWIRE
TOLREMO’s TT125-802 Shows First CBP/p300 Activity in Solid Tumors
04 Jun 2025 //
GLOBENEWSWIRE
TOLREMO Adds Lung Cancer Expert Pasi A. to Advisory Board
25 Mar 2025 //
BUSINESSWIRE
TOLREMO Welcomes Dr. Alan Sandler to Scientific Advisory Board
08 May 2024 //
BUSINESSWIRE
TOLREMO Appoints Industry Veterans Jonker and Mike Sherman to Board of Directors
21 Mar 2024 //
BUSINESSWIRE
TOLREMO Treats First Patient in Phase I Trial with TT125-802
28 Nov 2023 //
BUSINESSWIRE
TOLREMO therapeutics Completes USD 39 Million Series A Financing Round
20 Sep 2023 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.